 | • レポートコード：MRC2-11QY01427 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒトB型肝炎免疫グロブリンのグローバル市場について調査・分析したレポートです。種類別（100IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、200IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、400IU/ボトルヒトB型肝炎免疫グロブリン（HBIG））市場規模、用途別（B型肝炎キャリア、B型肝炎密接）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒトB型肝炎免疫グロブリンの競争状況、市場シェア ・世界のヒトB型肝炎免疫グロブリン市場：種類別市場規模 2015年-2020年（100IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、200IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、400IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）） ・世界のヒトB型肝炎免疫グロブリン市場：種類別市場規模予測 2021年-2026年（100IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、200IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、400IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）） ・世界のヒトB型肝炎免疫グロブリン市場：用途別市場規模 2015年-2020年（B型肝炎キャリア、B型肝炎密接） ・世界のヒトB型肝炎免疫グロブリン市場：用途別市場規模予測 2021年-2026年（B型肝炎キャリア、B型肝炎密接） ・北米のヒトB型肝炎免疫グロブリン市場分析：米国、カナダ ・ヨーロッパのヒトB型肝炎免疫グロブリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒトB型肝炎免疫グロブリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒトB型肝炎免疫グロブリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒトB型肝炎免疫グロブリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、CSL、Bayer、Grifols、Octapharma、Shanghai RAAS、Hualan Biological、China Biologic、Tiantan Biologic、Shuanglin Bio-pharmacy、Sichuan Yuanda Shuyang、Boya Bio-pharmaceutical、Shanghai Institute of Biological ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin Market
The global Human Hepatitis B Immunoglobulin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Hepatitis B Immunoglobulin Scope and Market Size
Human Hepatitis B Immunoglobulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Hepatitis B Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Hepatitis B Immunoglobulin market is segmented into
100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Segment by Application, the Human Hepatitis B Immunoglobulin market is segmented into
Hepatitis B Carrier
Hepatitis B Close Contacts
Regional and Country-level Analysis
The Human Hepatitis B Immunoglobulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Hepatitis B Immunoglobulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Hepatitis B Immunoglobulin Market Share Analysis
Human Hepatitis B Immunoglobulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Hepatitis B Immunoglobulin business, the date to enter into the Human Hepatitis B Immunoglobulin market, Human Hepatitis B Immunoglobulin product introduction, recent developments, etc.
The major vendors covered:
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
1 Study Coverage
1.1 Human Hepatitis B Immunoglobulin Product Introduction
1.2 Market Segments
1.3 Key Human Hepatitis B Immunoglobulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Type
1.4.2 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.4.3 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.4.4 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.5 Market by Application
1.5.1 Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Application
1.5.2 Hepatitis B Carrier
1.5.3 Hepatitis B Close Contacts
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Hepatitis B Immunoglobulin Market Size, Estimates and Forecasts
2.1.1 Global Human Hepatitis B Immunoglobulin Revenue 2015-2026
2.1.2 Global Human Hepatitis B Immunoglobulin Sales 2015-2026
2.2 Global Human Hepatitis B Immunoglobulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Hepatitis B Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Hepatitis B Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Hepatitis B Immunoglobulin Competitor Landscape by Players
3.1 Human Hepatitis B Immunoglobulin Sales by Manufacturers
3.1.1 Human Hepatitis B Immunoglobulin Sales by Manufacturers (2015-2020)
3.1.2 Human Hepatitis B Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
3.2 Human Hepatitis B Immunoglobulin Revenue by Manufacturers
3.2.1 Human Hepatitis B Immunoglobulin Revenue by Manufacturers (2015-2020)
3.2.2 Human Hepatitis B Immunoglobulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Hepatitis B Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Hepatitis B Immunoglobulin Revenue in 2019
3.2.5 Global Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Hepatitis B Immunoglobulin Price by Manufacturers
3.4 Human Hepatitis B Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Human Hepatitis B Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Hepatitis B Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Hepatitis B Immunoglobulin Market Size by Type (2015-2020)
4.1.1 Global Human Hepatitis B Immunoglobulin Sales by Type (2015-2020)
4.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Type (2015-2020)
4.1.3 Human Hepatitis B Immunoglobulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Hepatitis B Immunoglobulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Hepatitis B Immunoglobulin Sales Forecast by Type (2021-2026)
4.2.2 Global Human Hepatitis B Immunoglobulin Revenue Forecast by Type (2021-2026)
4.2.3 Human Hepatitis B Immunoglobulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Hepatitis B Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Hepatitis B Immunoglobulin Market Size by Application (2015-2020)
5.1.1 Global Human Hepatitis B Immunoglobulin Sales by Application (2015-2020)
5.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Application (2015-2020)
5.1.3 Human Hepatitis B Immunoglobulin Price by Application (2015-2020)
5.2 Human Hepatitis B Immunoglobulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Hepatitis B Immunoglobulin Sales Forecast by Application (2021-2026)
5.2.2 Global Human Hepatitis B Immunoglobulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Hepatitis B Immunoglobulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Hepatitis B Immunoglobulin by Country
6.1.1 North America Human Hepatitis B Immunoglobulin Sales by Country
6.1.2 North America Human Hepatitis B Immunoglobulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Hepatitis B Immunoglobulin Market Facts & Figures by Type
6.3 North America Human Hepatitis B Immunoglobulin Market Facts & Figures by Application
7 Europe
7.1 Europe Human Hepatitis B Immunoglobulin by Country
7.1.1 Europe Human Hepatitis B Immunoglobulin Sales by Country
7.1.2 Europe Human Hepatitis B Immunoglobulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Hepatitis B Immunoglobulin Market Facts & Figures by Type
7.3 Europe Human Hepatitis B Immunoglobulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Hepatitis B Immunoglobulin by Region
8.1.1 Asia Pacific Human Hepatitis B Immunoglobulin Sales by Region
8.1.2 Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Hepatitis B Immunoglobulin Market Facts & Figures by Type
8.3 Asia Pacific Human Hepatitis B Immunoglobulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Hepatitis B Immunoglobulin by Country
9.1.1 Latin America Human Hepatitis B Immunoglobulin Sales by Country
9.1.2 Latin America Human Hepatitis B Immunoglobulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Hepatitis B Immunoglobulin Market Facts & Figures by Type
9.3 Central & South America Human Hepatitis B Immunoglobulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Hepatitis B Immunoglobulin by Country
10.1.1 Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country
10.1.2 Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Hepatitis B Immunoglobulin Market Facts & Figures by Type
10.3 Middle East and Africa Human Hepatitis B Immunoglobulin Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Human Hepatitis B Immunoglobulin Products Offered
11.1.5 Baxter Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Human Hepatitis B Immunoglobulin Products Offered
11.2.5 CSL Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Human Hepatitis B Immunoglobulin Products Offered
11.3.5 Bayer Related Developments
11.4 Grifols
11.4.1 Grifols Corporation Information
11.4.2 Grifols Description and Business Overview
11.4.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Grifols Human Hepatitis B Immunoglobulin Products Offered
11.4.5 Grifols Related Developments
11.5 Octapharma
11.5.1 Octapharma Corporation Information
11.5.2 Octapharma Description and Business Overview
11.5.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Octapharma Human Hepatitis B Immunoglobulin Products Offered
11.5.5 Octapharma Related Developments
11.6 Shanghai RAAS
11.6.1 Shanghai RAAS Corporation Information
11.6.2 Shanghai RAAS Description and Business Overview
11.6.3 Shanghai RAAS Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Products Offered
11.6.5 Shanghai RAAS Related Developments
11.7 Hualan Biological
11.7.1 Hualan Biological Corporation Information
11.7.2 Hualan Biological Description and Business Overview
11.7.3 Hualan Biological Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Products Offered
11.7.5 Hualan Biological Related Developments
11.8 China Biologic
11.8.1 China Biologic Corporation Information
11.8.2 China Biologic Description and Business Overview
11.8.3 China Biologic Sales, Revenue and Gross Margin (2015-2020)
11.8.4 China Biologic Human Hepatitis B Immunoglobulin Products Offered
11.8.5 China Biologic Related Developments
11.9 Tiantan Biologic
11.9.1 Tiantan Biologic Corporation Information
11.9.2 Tiantan Biologic Description and Business Overview
11.9.3 Tiantan Biologic Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Products Offered
11.9.5 Tiantan Biologic Related Developments
11.10 Shuanglin Bio-pharmacy
11.10.1 Shuanglin Bio-pharmacy Corporation Information
11.10.2 Shuanglin Bio-pharmacy Description and Business Overview
11.10.3 Shuanglin Bio-pharmacy Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Products Offered
11.10.5 Shuanglin Bio-pharmacy Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Human Hepatitis B Immunoglobulin Products Offered
11.1.5 Baxter Related Developments
11.12 Boya Bio-pharmaceutical
11.12.1 Boya Bio-pharmaceutical Corporation Information
11.12.2 Boya Bio-pharmaceutical Description and Business Overview
11.12.3 Boya Bio-pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Boya Bio-pharmaceutical Products Offered
11.12.5 Boya Bio-pharmaceutical Related Developments
11.13 Shanghai Institute of Biological
11.13.1 Shanghai Institute of Biological Corporation Information
11.13.2 Shanghai Institute of Biological Description and Business Overview
11.13.3 Shanghai Institute of Biological Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Shanghai Institute of Biological Products Offered
11.13.5 Shanghai Institute of Biological Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Hepatitis B Immunoglobulin Market Estimates and Projections by Region
12.1.1 Global Human Hepatitis B Immunoglobulin Sales Forecast by Regions 2021-2026
12.1.2 Global Human Hepatitis B Immunoglobulin Revenue Forecast by Regions 2021-2026
12.2 North America Human Hepatitis B Immunoglobulin Market Size Forecast (2021-2026)
12.2.1 North America: Human Hepatitis B Immunoglobulin Sales Forecast (2021-2026)
12.2.2 North America: Human Hepatitis B Immunoglobulin Revenue Forecast (2021-2026)
12.2.3 North America: Human Hepatitis B Immunoglobulin Market Size Forecast by Country (2021-2026)
12.3 Europe Human Hepatitis B Immunoglobulin Market Size Forecast (2021-2026)
12.3.1 Europe: Human Hepatitis B Immunoglobulin Sales Forecast (2021-2026)
12.3.2 Europe: Human Hepatitis B Immunoglobulin Revenue Forecast (2021-2026)
12.3.3 Europe: Human Hepatitis B Immunoglobulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Hepatitis B Immunoglobulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Hepatitis B Immunoglobulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Hepatitis B Immunoglobulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Hepatitis B Immunoglobulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Hepatitis B Immunoglobulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Hepatitis B Immunoglobulin Sales Forecast (2021-2026)
12.5.2 Latin America: Human Hepatitis B Immunoglobulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Hepatitis B Immunoglobulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Hepatitis B Immunoglobulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Hepatitis B Immunoglobulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Hepatitis B Immunoglobulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Hepatitis B Immunoglobulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Hepatitis B Immunoglobulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Hepatitis B Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Hepatitis B Immunoglobulin Market Segments
Table 2. Ranking of Global Top Human Hepatitis B Immunoglobulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 5. Major Manufacturers of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 6. Major Manufacturers of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 7. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Human Hepatitis B Immunoglobulin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Human Hepatitis B Immunoglobulin Sales by Regions 2015-2020 (K MT)
Table 10. Global Human Hepatitis B Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 11. Global Human Hepatitis B Immunoglobulin Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Human Hepatitis B Immunoglobulin Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Human Hepatitis B Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 14. Global Human Hepatitis B Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Human Hepatitis B Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin as of 2019)
Table 16. Human Hepatitis B Immunoglobulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Human Hepatitis B Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Human Hepatitis B Immunoglobulin Price (2015-2020) (USD/MT)
Table 19. Human Hepatitis B Immunoglobulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Human Hepatitis B Immunoglobulin Product Type
Table 21. Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Hepatitis B Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 24. Global Human Hepatitis B Immunoglobulin Sales Share by Type (2015-2020)
Table 25. Global Human Hepatitis B Immunoglobulin Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Human Hepatitis B Immunoglobulin Revenue Share by Type (2015-2020)
Table 27. Human Hepatitis B Immunoglobulin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Human Hepatitis B Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 29. Global Human Hepatitis B Immunoglobulin Sales Share by Application (2015-2020)
Table 30. North America Human Hepatitis B Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 31. North America Human Hepatitis B Immunoglobulin Sales Market Share by Country (2015-2020)
Table 32. North America Human Hepatitis B Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 34. North America Human Hepatitis B Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 35. North America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2015-2020)
Table 36. North America Human Hepatitis B Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 37. North America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2015-2020)
Table 38. Europe Human Hepatitis B Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 39. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Country (2015-2020)
Table 40. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 42. Europe Human Hepatitis B Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 43. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2015-2020)
Table 44. Europe Human Hepatitis B Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 45. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Application (2015-2020)
Table 54. Latin America Human Hepatitis B Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 55. Latin America Human Hepatitis B Immunoglobulin Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Human Hepatitis B Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 58. Latin America Human Hepatitis B Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 59. Latin America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2015-2020)
Table 60. Latin America Human Hepatitis B Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 61. Latin America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Application (2015-2020)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Major Businesses
Table 72. Baxter Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Baxter Product
Table 74. Baxter Recent Development
Table 75. CSL Corporation Information
Table 76. CSL Description and Major Businesses
Table 77. CSL Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. CSL Product
Table 79. CSL Recent Development
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Major Businesses
Table 82. Bayer Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bayer Product
Table 84. Bayer Recent Development
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Major Businesses
Table 87. Grifols Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Grifols Product
Table 89. Grifols Recent Development
Table 90. Octapharma Corporation Information
Table 91. Octapharma Description and Major Businesses
Table 92. Octapharma Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Octapharma Product
Table 94. Octapharma Recent Development
Table 95. Shanghai RAAS Corporation Information
Table 96. Shanghai RAAS Description and Major Businesses
Table 97. Shanghai RAAS Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Shanghai RAAS Product
Table 99. Shanghai RAAS Recent Development
Table 100. Hualan Biological Corporation Information
Table 101. Hualan Biological Description and Major Businesses
Table 102. Hualan Biological Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Hualan Biological Product
Table 104. Hualan Biological Recent Development
Table 105. China Biologic Corporation Information
Table 106. China Biologic Description and Major Businesses
Table 107. China Biologic Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. China Biologic Product
Table 109. China Biologic Recent Development
Table 110. Tiantan Biologic Corporation Information
Table 111. Tiantan Biologic Description and Major Businesses
Table 112. Tiantan Biologic Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Tiantan Biologic Product
Table 114. Tiantan Biologic Recent Development
Table 115. Shuanglin Bio-pharmacy Corporation Information
Table 116. Shuanglin Bio-pharmacy Description and Major Businesses
Table 117. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Shuanglin Bio-pharmacy Product
Table 119. Shuanglin Bio-pharmacy Recent Development
Table 120. Sichuan Yuanda Shuyang Corporation Information
Table 121. Sichuan Yuanda Shuyang Description and Major Businesses
Table 122. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Sichuan Yuanda Shuyang Product
Table 124. Sichuan Yuanda Shuyang Recent Development
Table 125. Boya Bio-pharmaceutical Corporation Information
Table 126. Boya Bio-pharmaceutical Description and Major Businesses
Table 127. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Boya Bio-pharmaceutical Product
Table 129. Boya Bio-pharmaceutical Recent Development
Table 130. Shanghai Institute of Biological Corporation Information
Table 131. Shanghai Institute of Biological Description and Major Businesses
Table 132. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Shanghai Institute of Biological Product
Table 134. Shanghai Institute of Biological Recent Development
Table 135. Global Human Hepatitis B Immunoglobulin Sales Forecast by Regions (2021-2026) (K MT)
Table 136. Global Human Hepatitis B Immunoglobulin Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Human Hepatitis B Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 140. North America: Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Human Hepatitis B Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 142. Europe: Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Human Hepatitis B Immunoglobulin Sales Forecast by Region (2021-2026) (K MT)
Table 144. Asia Pacific: Human Hepatitis B Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Human Hepatitis B Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 146. Latin America: Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Human Hepatitis B Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 148. Middle East and Africa: Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Human Hepatitis B Immunoglobulin Players
Table 153. Human Hepatitis B Immunoglobulin Customers List
Table 154. Human Hepatitis B Immunoglobulin Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin Product Picture
Figure 2. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020 & 2026
Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 6. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020 & 2026
Figure 7. Hepatitis B Carrier
Figure 8. Hepatitis B Close Contacts
Figure 9. Human Hepatitis B Immunoglobulin Report Years Considered
Figure 10. Global Human Hepatitis B Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 11. Global Human Hepatitis B Immunoglobulin Sales 2015-2026 (K MT)
Figure 12. Global Human Hepatitis B Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 14. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region in 2019
Figure 15. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 16. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region in 2019
Figure 17. Global Human Hepatitis B Immunoglobulin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Human Hepatitis B Immunoglobulin Revenue in 2019
Figure 19. Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2015-2020)
Figure 21. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2019
Figure 22. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2015-2020)
Figure 23. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type in 2019
Figure 24. Global Human Hepatitis B Immunoglobulin Market Share by Price Range (2015-2020)
Figure 25. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 26. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2019
Figure 27. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2015-2020)
Figure 28. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application in 2019
Figure 29. North America Human Hepatitis B Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Human Hepatitis B Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2019
Figure 32. North America Human Hepatitis B Immunoglobulin Revenue Market Share by Country in 2019
Figure 33. U.S. Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Human Hepatitis B Immunoglobulin Market Share by Type in 2019
Figure 38. North America Human Hepatitis B Immunoglobulin Market Share by Application in 2019
Figure 39. Europe Human Hepatitis B Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Human Hepatitis B Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2019
Figure 42. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Country in 2019
Figure 43. Germany Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Human Hepatitis B Immunoglobulin Market Share by Type in 2019
Figure 54. Europe Human Hepatitis B Immunoglobulin Market Share by Application in 2019
Figure 55. Asia Pacific Human Hepatitis B Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Market Share by Region in 2019
Figure 59. China Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Human Hepatitis B Immunoglobulin Market Share by Type in 2019
Figure 82. Asia Pacific Human Hepatitis B Immunoglobulin Market Share by Application in 2019
Figure 83. Latin America Human Hepatitis B Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Human Hepatitis B Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2019
Figure 86. Latin America Human Hepatitis B Immunoglobulin Revenue Market Share by Country in 2019
Figure 87. Mexico Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Human Hepatitis B Immunoglobulin Market Share by Type in 2019
Figure 94. Latin America Human Hepatitis B Immunoglobulin Market Share by Application in 2019
Figure 95. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Country in 2019
Figure 99. Turkey Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Human Hepatitis B Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Human Hepatitis B Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Human Hepatitis B Immunoglobulin Market Share by Type in 2019
Figure 106. Middle East and Africa Human Hepatitis B Immunoglobulin Market Share by Application in 2019
Figure 107. North America Human Hepatitis B Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Human Hepatitis B Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Human Hepatitis B Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Human Hepatitis B Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Human Hepatitis B Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Human Hepatitis B Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Human Hepatitis B Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
免疫グロブリンの世界市場（～2026年） Market Analysis and Insights: Global Immunoglobulin Market The global Immunoglobulin market size is projected to reach US$ 9025.1 million by 2026, from US$ 8538.2 million in 2020, at a CAGR of 5.3%% during 2021-2026. Global Immunoglobulin Scope and Market Size Immunoglobulin market is segmented by T…- ヒト血漿由来治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Plasma-Derived Therapeutics Scope and Mar…
- 低親和性免疫グロブリンガンマFc領域受容体II-bの世界市場（～2026年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…
- 免疫グロブリン製品の世界市場（～2026年） Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. …
- B型肝炎ウイルス（HBV）の世界市場（～2026年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…